Genzyme v. TKT Patent Appeal Is Second Front In Orphan Exclusivity Battle
Executive Summary
An appeals court decision in the Genzyme v. Transkaryotic Therapies patent case could have implications for the marketing of the companies' Fabry disease products in the U.S. and Europe